• Linda Hughes, Jean Adair, Feng Feng, Stephanie Maciejewski, and Harsha Sharma.
• Linda Hughes, PhD, RN, Dean of Nursing and Professor, Nebraska Methodist College, Omaha. Jean Adair, MSN, RN, Learning Consultant, Nebraska Methodist College, Omaha. Feng Feng, MD, PhD, Associate Professor, Nebraska Methodist College, Omaha. Stephanie Maciejewski, Pharm D, Medical Outcomes Specialist, Pfizer Inc., New York. Harsha Sharma, PhD, Associate Professor, Nebraska Methodist College, Omaha.
• Orthop Nurs. 2016 Sep 1; 35 (5): 317-22.

BackgroundIn the United States, fibromyalgia affects 2%-5% of the adult population, rendering it the most common chronic, widespread pain condition. The American College of Rheumatology has published diagnostic criteria for fibromyalgia, with the latest version in 2010.PurposeThe purpose of this study was to evaluate nurse practitioners' education and awareness of fibromyalgia and to evaluate nurse practitioners' practices for the management of fibromyalgia.MethodsSixty-six nurse practitioners voluntarily completed an online survey regarding their education, diagnosis, and treatment options for patients with fibromyalgia.ResultsThe majority of participants reported that they always or occasionally had difficulty diagnosing fibromyalgia and worried about labeling their patients as having fibromyalgia. The most commonly used agents were nonsteroidal anti-inflammatory drugs (70%), serotonin norepinephrine reuptake inhibitors (61%), selective serotonin reuptake inhibitors (51%), and muscle relaxants (44%). Nondrug therapies included exercise (88%), cognitive behavior therapy (58%), and nutrition (56%).ConclusionFurther education is needed for nurse practitioners to increase confidence in diagnosing and managing fibromyalgia.

20 keywords...

hide…